drugset / Trial / NCT05116111
A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to evaluate the safety, tolerance, pharmacokinetics/pharmacodynamics and efficacy of SYHA1402 tablets for the treatment of patients with diabetic peripheral neuropathy (DPN) in China.
Timeline
- Start
- 2021-12-31
- Primary completion
- 2023-05-15
- Completion
- 2023-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYHA1402 | Unknown | 1000 mg | Oral |
| Subject | SYHA1402 | Unknown | 1500 mg | Oral |